Outcomes of Patients Undergoing Elective Pancreatic Surgery During COVID-19 Pandemic: A Multicenter, Prospective Cohort Study
Cancer Screening and Prevention · 2023
DOI: 10.14218/csp.2023.00001s ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cancer Screening and Prevention, 2023. Verfasst von Ning Pu und 8 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The coronavirus disease 2019 (COVID-19) pandemic continues to affect global health, and the emergence of new variants has added a layer of uncertainty to medical practice. Although elective surgeries are recommended to be postponed for at least 7 weeks after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection to be considered safe, the safety and optimal timing for pancreatic surgery after this infection remains unknown.
Zitieren
APA
Pu, N., Liu, S., Bai, X., Yang, J., Qian, T., Wei, Z., Ma, T., Cai, L., & Wu, W. (2023). Outcomes of Patients Undergoing Elective Pancreatic Surgery During COVID-19 Pandemic: A Multicenter, Prospective Cohort Study. Cancer Screening and Prevention. https://doi.org/10.14218/csp.2023.00001s
Vancouver
Pu N, Liu S, Bai X, Yang J, Qian T, Wei Z, et al. Outcomes of Patients Undergoing Elective Pancreatic Surgery During COVID-19 Pandemic: A Multicenter, Prospective Cohort Study. Cancer Screening and Prevention. 2023. doi:10.14218/csp.2023.00001s
BibTeX
@article{Pu2023,
author = {Pu, Ning and Liu, Siyao and Bai, Xuewei and Yang, Jiali and Qian, Tao and Wei, Zixian and Ma, Tao and Cai, Lei and Wu, Wenchuan},
title = {Outcomes of Patients Undergoing Elective Pancreatic Surgery During COVID-19 Pandemic: A Multicenter, Prospective Cohort Study},
journal = {Cancer Screening and Prevention},
year = {2023},
doi = {10.14218/csp.2023.00001s}
}
EUVIMED